Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Zotepine for schizophrenia.

P DeSilva1, M Fenton, J Rathbone

  • 1The Anchorage, 11 Byland Road, Whitby, Yorkshire, UK. lillian.atkinson@tney.northy.nhs.uk

The Cochrane Database of Systematic Reviews
|October 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study.

Breast cancer research and treatment·2021
Same author

How to interpret a paediatric echocardiography report.

BJA education·2021
Same author

Wide dynamic range magnetic field cycler: Harnessing quantum control at low and high fields.

The Review of scientific instruments·2019
Same author

Comparative Study of Pediatric Coronary Allograft Vasculopathy Between Single Centers in North America and United Kingdom.

Transplantation proceedings·2018
Same author

A systematic review of the public's knowledge and beliefs about antibiotic resistance-authors' response.

The Journal of antimicrobial chemotherapy·2016
Same author

Inflammatory Cytokines, Endothelial Function, and Chronic Allograft Vasculopathy in Children: An Investigation of the Donor and Recipient Vasculature After Heart Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Zotepine, an antipsychotic for schizophrenia, shows promise for improving mental state compared to placebo and may have fewer movement side effects than typical antipsychotics.

Area of Science:

  • Psychiatry and Pharmacology
  • Clinical Neuroscience

Background:

  • Zotepine is an atypical antipsychotic medication used in schizophrenia treatment.
  • It is recognized for its potential efficacy in managing negative symptoms of schizophrenia.

Purpose of the Study:

  • To evaluate the comparative effectiveness of zotepine against placebo and other antipsychotic drugs.
  • To assess zotepine's impact on schizophrenia and related psychotic disorders.

Main Methods:

  • Systematic review of randomized clinical trials from the Cochrane Schizophrenia Group register.
  • Inclusion of 11 trials with 966 participants, focusing on short-term outcomes (4-12 weeks).
  • Statistical analysis using relative risk and weighted mean differences, with intention-to-treat analysis.

Related Experiment Videos

Main Results:

  • Zotepine improved mental state ratings compared to placebo (NNT=3).
  • Zotepine demonstrated comparable efficacy to typical antipsychotics and showed improvement over other active drugs for mental state (NNT=7).
  • Zotepine may cause fewer movement disorders than typical antipsychotics, with no clear differences noted compared to other atypicals.

Conclusions:

  • Zotepine presents a potential addition to atypical antipsychotic options for schizophrenia.
  • Further high-quality, long-term randomized trials are essential to confirm findings and guide clinical practice.
  • Current evidence relies on short-term data, necessitating more comprehensive research for robust conclusions.